InsiderFlow

Neurocrine Biosciences, Inc.

$129.43+1.65 (+1.29%)

Prev Close

$127.78

Open

$128.64

High

$130.72

Low

$128.05

Volume

646.5K

Market Cap

$13.13B

P/E

27.78

Div Yield

Over the past 12 months, insider activity at Neurocrine Biosciences, Inc. (NBIX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 10 insider sales totaling $20.31M. The most recent insider transaction was by GORMAN KEVIN CHARLES (Director), who sold $5.00M worth of shares on Feb 17, 2026. Neurocrine Biosciences, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $13.13B.

Buys (12M)

0

$0.00

Sells (12M)

10

$20.31M

Net Activity

Net Seller

$20.31M

Active Insiders

9

last 12 mo

NBIX Price Chart

NBIX Insider Trading Activity

DateInsiderRoleTypeSharesAvg PriceValueShares After
Feb 17, 2026GORMAN KEVIN CHARLESDirectorSell40,305$124.12$5.00M0
Feb 12, 2026ABERNETHY MATTChief Financial OfficerSell9,124$123.99$1.13M0
Feb 12, 2026BENEVICH ERICChief Commercial OfficerSell12,227$124.03$1.52M0
Feb 12, 2026Boyer David W.Chief Corp. Affairs OfficerSell8,052$124.01$998.5K0
Feb 12, 2026Cooke JulieChief Human Resources OfficerSell7,698$124.02$954.7K0
Feb 12, 2026Delaet IngridChief Regulatory OfficerSell13,126$124.05$1.63M0
Feb 12, 2026Gano KyleChief Executive OfficerSell10,621$123.87$1.32M0
Feb 12, 2026Lippoldt DarinChief Legal OfficerSell8,558$124.00$1.06M0
Feb 12, 2026Onyia JudeChief Scientific OfficerSell15,099$124.02$1.87M0
Jan 20, 2026Gano Kyledirector, officer: Chief Executive OfficerSell36,400$132.70$4.83M140,407

NBIX Insider Buying Activity

The following table shows recent insider purchases of Neurocrine Biosciences, Inc. (NBIX) stock reported via SEC Form 4 filings.

No insider buying activity found for NBIX in the last 12 months.

NBIX Insider Selling Activity

The following table shows recent insider sales of Neurocrine Biosciences, Inc. (NBIX) stock reported via SEC Form 4 filings.

DateInsiderRoleTypeSharesAvg PriceValueShares After
Feb 17, 2026GORMAN KEVIN CHARLESDirectorSell40,305$124.12$5.00M0
Feb 12, 2026ABERNETHY MATTChief Financial OfficerSell9,124$123.99$1.13M0
Feb 12, 2026BENEVICH ERICChief Commercial OfficerSell12,227$124.03$1.52M0
Feb 12, 2026Boyer David W.Chief Corp. Affairs OfficerSell8,052$124.01$998.5K0
Feb 12, 2026Cooke JulieChief Human Resources OfficerSell7,698$124.02$954.7K0
Feb 12, 2026Delaet IngridChief Regulatory OfficerSell13,126$124.05$1.63M0
Feb 12, 2026Gano KyleChief Executive OfficerSell10,621$123.87$1.32M0
Feb 12, 2026Lippoldt DarinChief Legal OfficerSell8,558$124.00$1.06M0
Feb 12, 2026Onyia JudeChief Scientific OfficerSell15,099$124.02$1.87M0
Jan 20, 2026Gano Kyledirector, officer: Chief Executive OfficerSell36,400$132.70$4.83M140,407

NBIX Insiders

ABERNETHY MATT

Chief Financial Officer

Sold $1.13M
4 tradesLast: Feb 13, 2026
BENEVICH ERIC

Chief Commercial Officer

Sold $1.52M
4 tradesLast: Feb 13, 2026
Boyer David W.

Chief Corp. Affairs Officer

Sold $998.5K
4 tradesLast: Feb 13, 2026
Cooke Julie

Chief Human Resources Officer

Sold $954.7K
4 tradesLast: Feb 13, 2026
Delaet Ingrid

Chief Regulatory Officer

Sold $1.63M
4 tradesLast: Feb 13, 2026
Gano Kyle

Chief Executive Officer

Sold $1.32M
4 tradesLast: Feb 13, 2026
GORMAN KEVIN CHARLES

Director

Sold $5.00M
3 tradesLast: Feb 13, 2026
Lippoldt Darin

Chief Legal Officer

Sold $1.06M
4 tradesLast: Feb 13, 2026
Onyia Jude

Chief Scientific Officer

Sold $1.87M
4 tradesLast: Feb 13, 2026
Gano Kyle

director, officer: Chief Executive Officer

Sold $4.83M
2 tradesLast: Jan 16, 2026